Discover B2B companies, suppliers, and manufacturers related to this keyword category
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer
From promising to validated immuno-therapeutics: GEM design and humanization, profiling solutions for your candidate
Integrating high-throughput patient-derived biology with AI/ML to dramatically increase the success of cancer therapy.
Specialists in antibody sequencing, engineering, and recombinant manufacturing.
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases.